Health

AI ยท 251 companies ยท 438 deals tracked
251 Companies
438 Deals Tracked
AI Sector

Health Companies

Centauri Therapeutics Centauri Therapeutics ๐Ÿ‡ฌ๐Ÿ‡ง TandemAI TandemAI ๐Ÿ‡บ๐Ÿ‡ธ Codoxo Codoxo ๐Ÿ‡บ๐Ÿ‡ธ Outpost Bio Outpost Bio ๐Ÿ‡ฌ๐Ÿ‡ง Holo Holo ๐Ÿ‡ช๐Ÿ‡ธ Amigo AI Amigo AI ๐Ÿ‡บ๐Ÿ‡ธ University Of Cincinnatiโ€™s Venture Lab University Of Cincinnatiโ€™s Venture Lab ๐Ÿ‡บ๐Ÿ‡ธ Emerald ๐Ÿ‡ฌ๐Ÿ‡ง Coherence Neuro Coherence Neuro ๐Ÿ‡บ๐Ÿ‡ธ Rakuten Medical Rakuten Medical ๐Ÿ‡ฏ๐Ÿ‡ต

Latest Deals in Health

$52.5M
Biorce, a Barcelona-based health AI company, has raised $52.5 million in a Series A funding round to enhance its international expansion and scale its AI platform, Aika, aimed at improving clinical trial design and execution.
Health Feb 3, 2026
$52M
Biorce, a health AI company based in Barcelona, Spain, raised $52 million in Series A funding to enhance the design and execution of clinical trials using artificial intelligence. The funding round was backed by notable investors including DST Global Partners, Norrsken VC, and others.
Investors: DST Global Partners, Norrsken VC
Health Feb 2, 2026
$47.304M
Biorce, a healthtech company based in Barcelona, has secured โ‚ฌ43.8 million ($52 million) in a Series A funding round to enhance its AI platform, Aika, which aims to streamline clinical trials and reduce costs by over 50%. The round was led by DST Global Partners, with support from existing investors Norrsken VC and YZR Capital, and notable angel investors. This funding marks the largest Series A in the Iberian healthtech and AI sector, enabling Biorce to expand internationally and grow its team significantly.
Investors: DST Global Partners, Norrsken VC, YZR Capital
Health Feb 2, 2026
$52M
Barcelona-based Biorce, a health AI company focused on clinical trial design, has secured a $52 million Series A funding round led by DST Global Partners, with increased participation from existing investors Norrsken VC and YZR Capital, along with angel investors. This funding aims to enhance Biorce's AI platform, Aika, which addresses inefficiencies in clinical trials, reducing preparation timelines and costs associated with protocol amendments. Total funding has now surpassed $60 million.
Investors: DST Global Partners, Norrsken VC, YZR Capital
Health Feb 2, 2026
$39.96M
recare, a Berlin-based provider of technology for hospitals and care providers, has secured a growth financing round of up to โ‚ฌ37 million, including a โ‚ฌ7 million option. This funding will help accelerate the rollout of their AI agent platform aimed at improving discharge management and aftercare. DNV has become the largest shareholder following this investment.
Investors: DNV
Health Jan 30, 2026
$1875M
UK Research and Innovation (UKRI) plans to invest ยฃ1.5 billion over the next four years to enhance life sciences research in the UK. This funding aims to support institutions like the MRC Laboratory of Molecular Biology, known for its significant contributions to healthcare advancements. The initiative is expected to foster long-term stability and encourage further breakthroughs in the sector.
Health Jan 30, 2026
$1.1M
Mos Health, a Polish-American startup, has raised $1.1 million in a pre-seed round co-led by Smok Ventures and Movens Capital. The company addresses the execution gap in health and wellness by providing personalized health protocols and supplements through an AI-based platform. The platform analyzes data from various sources to generate tailored health recommendations, aiming to improve adherence to health guidelines. The funding will be used to develop its MVP and advance technology for initial deployments in the U.S.
Investors: Smok Ventures, Movens Capital
Health Jan 30, 2026
$0.9936M
Mos Health, a Polish-American startup, has raised nearly โ‚ฌ920,000 ($1.1 million) in a pre-seed round to develop an AI health partner that delivers personalized health protocols and supplements. The funding will help build its MVP and launch in the U.S. The round was co-led by Smok Ventures and Movens Capital, with participation from various investors. The company aims to address the execution gap in health and wellness by providing tailored solutions for individuals and employers.
Investors: Smok Ventures, Movens Capital
Health Jan 30, 2026
$39.96M
Recare, a Berlin-based healthtech company, has secured up to โ‚ฌ37 million in growth financing to enhance its AI platform and expand internationally. The funding round was led by DNV, making them the largest shareholder, with participation from CIBC Innovation Banking. Recare aims to improve hospital operations and care coordination by automating administrative tasks, addressing the shortage of healthcare professionals in Europe. The investment will accelerate the rollout of its AI agent across Germany and beyond, connecting a significant portion of German hospitals and care providers.
Investors: DNV, CIBC Innovation Banking
Health Jan 30, 2026
$50M
Indigo, an AI-driven medical professional liability insurance platform, has secured $50 million in an oversubscribed Series B financing round. This funding aims to accelerate product development, expand distribution, and scale operations in its malpractice coverage business. The round was led by existing investor Rubicon Founders, with significant participation from new investor Town Hall Ventures and continued support from strategic investors, including Optum Ventures.
Investors: Rubicon Founders, Town Hall Ventures, Optum Ventures
Health Jan 30, 2026
$50M
Indigo, a Miami, FL-based provider of an AI-driven medical professional liability platform, raised $50 million in Series B funding. The round was led by Rubicon Founders, with participation from Town Hall Ventures and existing investors including Optum Ventures. The company plans to use the funds to expand research and development, enhance product capabilities, and grow distribution.
Investors: Rubicon Founders, Town Hall Ventures, Optum Ventures
Health Jan 29, 2026
$285M
Sword Health, based in New York, has acquired Kaia Health for $285 million to enhance its AI-driven care solutions for musculoskeletal conditions and expand into the German healthcare market. The acquisition aims to improve access to high-quality care and support Sword's rapid growth in the U.S. and Europe. With over 700,000 members and partnerships with over 1,000 enterprise clients, Sword has raised over $500 million from investors like Khosla Ventures and General Catalyst.
Investors: Khosla Ventures, General Catalyst
Health Jan 29, 2026
$2M
Emerald has secured $1.2 million in pre-seed funding, bringing its total to $2 million, led by Boost Capital Partners and including notable investors like Mark Fountain and several angel investors. The company addresses fragmented health information by providing baseline tests, a user-friendly dashboard, AI alerts, and personalized GP oversight. With over 10,000 users and a 15% monthly growth rate, Emerald shows strong market traction and aims to shift healthcare from reactive to proactive.
Investors: Boost Capital Partners, Mark Fountain
Health Jan 29, 2026
$2M
Emerald has secured $1.2 million in pre-seed funding, bringing its total to $2 million, led by Boost Capital Partners and including notable investors like Mark Fountain and several angel investors. The company addresses fragmented health information by providing baseline tests, a user-friendly dashboard, AI alerts, and personalized GP oversight. With over 10,000 users and a 15% monthly growth rate, Emerald shows strong market traction and aims to shift healthcare from reactive to proactive.
Investors: Boost Capital Partners, Mark Fountain
Health Jan 29, 2026
$21.6M
Samantree Medical, a Liรจge-based startup, has secured โ‚ฌ20 million in financing from the European Investment Bank to develop an advanced confocal microscopy scanner for rapid imaging of tissue microstructures during surgery. This funding, part of the EU's InvestEU program, positions Samantree among the larger rounds in the 2025 medtech funding landscape, aiming to enhance oncologic surgery through innovative imaging solutions. The histolog scanner has already shown significant impact in clinical settings, reducing reoperation rates and improving intraoperative assessments.
Investors: EIB
Health Jan 28, 2026
$100M
Tandem Technology, a New York-based healthcare AI startup, is raising $100 million in a funding round led by Accel, nearing a valuation of $1 billion. The company, which has previously raised $137 million, aims to automate prescription processing in the U.S. healthcare system, addressing significant bottlenecks. Its tools are offered at no cost to providers and patients, with plans to enhance collaboration with biopharma companies for drug development. Investor interest in healthcare AI solutions is strong, although key performance metrics have not been disclosed.
Investors: Accel
Health Jan 27, 2026
$22.68M
Norwich-based Evaro, an NHS-licensed digital healthcare platform, has raised โ‚ฌ21 million ($25 million) in Series A funding. The investment, led by AlbionVC with participation from SimplyHealth Ventures and others, will support Evaro's expansion into new treatment areas and enhance its API-first platform. Evaro aims to alleviate pressure on the NHS by providing regulated digital healthcare solutions, serving over 2 million patients, and plans to reach 10 million patients in the next three years.
Investors: AlbionVC, SimplyHealth Ventures
Health Jan 27, 2026
Eclipsebio Acquires Terrain Bio To Build An AI-Driven Design, Make, Test Platform or RNA Therapeutics
Health Jan 26, 2026
$11.88M
Aviwell SAS, a Toulouse-based deep-tech animal nutrition company, has secured โ‚ฌ11 million in Series A funding to enhance its AI-driven microbiome discovery platform and develop nature-based solutions for the agri-food sector, focusing on poultry and aquaculture. The funding round included new investors Blue Revolution Fund, Blast.Club, and Swen Capital Partners, alongside existing investors Elaia and MFS Investment Management.
Investors: Blue Revolution Fund, Blast.Club, Swen Capital Partners, Elaia, MFS Investment Management
Health Jan 26, 2026
$2M
Whistle Performance, a San Diego, CA-based provider of sports and human performance software, has closed a $2 million seed investment round to expand operations and development efforts. The company recently rebranded from GPS Dataviz, although specific backers were not disclosed.
Health Jan 26, 2026